Authors' reply to Comment on "No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance" [Dig. Liver Dis.2014;46:348-52]

Dig Liver Dis. 2014 Aug;46(8):762. doi: 10.1016/j.dld.2014.04.008. Epub 2014 Jun 2.

Authors

Ubaldo Visco-Comandini¹, Daniele Lapa², Chiara Taibi¹, Claudio Angeletti³

Affiliations

¹ Clinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzani", Rome, Italy.
² Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani", Rome, Italy. Electronic address: daniele.lapa@inmi.it.
³ Department of Epidemiology and Pre-clinical Research, National Institute for Infectious Diseases "Lazzaro Spallanzani", Rome, Italy.

PMID: 24890620
DOI: 10.1016/j.dld.2014.04.008

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents / therapeutic use*
Female
Hepatitis Antibodies / immunology*
Hepatitis D, Chronic / drug therapy*
Hepatitis Delta Virus / immunology*
Humans
Interferon-alpha / therapeutic use*
Interleukins / genetics*
Male
RNA, Viral / blood*

Substances

Antiviral Agents
Hepatitis Antibodies
Interferon-alpha
Interleukins
RNA, Viral